Instruments

Name Stock exchange Average volume Price Type
KIRBY CORPORATION KEX

Nyse +3 Other

576,384 114.4 USD Stock Kirby Corporation Stock
KIRBY CORPORATION KIY

Deutsche Boerse AG

- 105 EUR Stock Kirby Corporation
KIRBY CORPORATION KIY

Börse Stuttgart

- 104 EUR Stock Kirby Corporation
KIRBY CORPORATION KIY

BOERSE MUENCHEN

- 106 EUR Stock Kirby Corporation
KULTHORN KIRBY KKC

Thailand S.E.

51,297 0.19 THB Stock Kulthorn Kirby Stock
KULTHORN KIRBY KKC-R

Thailand S.E.

51,293 0.19 THB Stock Kulthorn Kirby Stock
FAKTOR-OPTIONSSCHEIN - KIRBY CO.

Börse Stuttgart

- - EUR Certificat FAKTOR-OPTIONSSCHEIN - KIRBY CO. Certificat
FAKTOR-OPTIONSSCHEIN - KIRBY CO.

Börse Stuttgart

- - EUR Certificat FAKTOR-OPTIONSSCHEIN - KIRBY CO. Certificat
FAKTOR-OPTIONSSCHEIN - KIRBY CO.

Börse Stuttgart

- 5.01 EUR Certificat FAKTOR-OPTIONSSCHEIN - KIRBY CO. Certificat
FAKTOR-OPTIONSSCHEIN - KIRBY CO.

Börse Stuttgart

- 12.62 EUR Certificat FAKTOR-OPTIONSSCHEIN - KIRBY CO. Certificat
FAKTOR-OPTIONSSCHEIN - KIRBY CO.

Börse Stuttgart

- 15.36 EUR Certificat FAKTOR-OPTIONSSCHEIN - KIRBY CO. Certificat
FAKTOR-OPTIONSSCHEIN - KIRBY CO.

Börse Stuttgart

- 9.24 EUR Certificat FAKTOR-OPTIONSSCHEIN - KIRBY CO. Certificat
FAKTOR-OPTIONSSCHEIN - KIRBY CO.

Börse Stuttgart

- 6.59 EUR Certificat FAKTOR-OPTIONSSCHEIN - KIRBY CO. Certificat

News (801)

Arthur J. Gallagher & Co. Acquires Acumen Advisors, Inc. PR
Arthur J. Gallagher & Co. acquired Acumen Advisors, Inc. CI
Invitation to attend the annual and the extraordinary shareholders’ meetings of the Company to be held on June 12, 2024 GL
Invitation to attend the annual and the extraordinary shareholders’ meetings of the Company to be held on June 12, 2024 AQ
CVS Health : 2024 Annual Report PU
Canadian Natural Resources Limited Announces 2024 First Quarter Results NE
Transcript : Hingham Institution for Savings - Shareholder/Analyst Call
The Taiwan Fund, Inc. Announces the Results of the Annual Stockholders Meeting PR
Pembina Pipeline : About Pembina Pipeline Corporation - Form 6-K PU
Kirby : 2024 Proxy Statement PU
Incyte Announces New Data from Phase 2 Study Evaluating Ruxolitinib Cream (Opzelura®) in Patients with Mild-to-Moderate Hidradenitis Suppurativa BU
MoonLake announces significant improvements with Nanobody® sonelokimab over 24 weeks in active psoriatic arthritis (PsA) and other important updates at its R&D Day AQ
MoonLake announces significant improvements with Nanobody® sonelokimab over 24 weeks in active psoriatic arthritis (PsA) and other important updates at its R&D Day GL
MoonLake Immunotherapeutics to present MIRA trial data of Nanobody® sonelokimab in hidradenitis suppurativa as a late breaker at the AAD Annual Meeting 2024 GL
Canadian Natural Resources Limited Announces 2023 Fourth Quarter and Year End Results NE
Kirby McInerney LLP Reminds Hut 8 Corp. (HUT) Investors of Class Action Filing and Encourages Investors to Contact the Firm BU
OceanaGold Reports Mineral Reserves and Resources for the Year Ended 2023 AQ
Kirby McInerney LLP Announces the Filing of a Securities Class Action on Behalf of Hut 8 Corp. (HUT) Investors BU
Kirby Corporation Announces 2023 Fourth Quarter and Full Year Results GL
Kirby Corporation Announces 2023 Fourth Quarter and Full Year Results AQ
Kirby Corporation Announces Management Changes, Effective April 26, 2024 CI
Kirby McInerney LLP Announces Investigation of Shareholder Claims Against Hut 8 Corp. (HUT) BU
European Commission Approves Pfizer’s TALZENNA® in Combination with XTANDI® for Adult Patients with Metastatic Castration-Resistant Prostate Cancer BU
Kirby McInerney LLP Reminds Investors That a Class Action Lawsuit Has Been Filed on Behalf of Microvast Holdings, Inc. (MVST) Investors and Encourages Investors to Contact the Firm Before February 5, 2024 BU
Bellicum Pharmaceuticals : 3730 Kirby Drive, Ste. 1200 Houston, TX 77098 - Form 8-K PU
OceanaGold Continues to Delineate High-Grade Gold Mineralization at Haile and Wharekirauponga AQ
Canadian Natural Resources Limited Announces 2024 Budget NE
Orrstown Financial Services, Inc. submits a non-binding term sheet to acquire Codorus Valley Bancorp, Inc. for approximately $210 million in a merger of equals transaction. CI
Kirby McInerney LLP Announces the Filing of a Securities Class Action on Behalf of Microvast Holdings, Inc. (MVST) Investors BU
Transcript : Washington H. Soul Pattinson and Company Limited - Shareholder/Analyst Call
Vaso Corporation entered into a business combination agreement to acquire Achari Ventures Holdings Corp. I from Achari Sponsor Holdings I LLC and others for approximately $190 million in a reverse merger transaction. CI
Canadian Natural Resources Limited Announces 2023 Third Quarter Results NE
OceanaGold : Q3 2023 MD&A PU
MoonLake Immunotherapeutics announces the full dataset from its 24-week MIRA clinical trial, establishing the Nanobody sonelokimab as a highly promising and differentiated therapeutic solution for Hidradenitis Suppurativa AQ
MoonLake Immunotherapeutics announces the full dataset from its 24-week MIRA clinical trial, establishing the Nanobody® sonelokimab as a highly promising and differentiated therapeutic solution for Hidradenitis Suppurativa AQ
MoonLake Immunotherapeutics announces the full dataset from its 24-week MIRA clinical trial, establishing the Nanobody® sonelokimab as a highly promising and differentiated therapeutic solution for Hidradenitis Suppurativa GL
UCB Reinforces Commitment to Advancing Care in Hidradenitis Suppurativa with Six Abstracts at SHSA 2023 CI
Data From Incyte’s Povorcitinib Clinical Program to Be Featured at the 8th Annual Symposium on Hidradenitis Suppurativa Advances (SHSA) BU
Phase 3 Data Analysis Presented at EADV 2023 Showed Bimekizumab Achieved High Thresholds of Clinical Response in Hidradenitis Suppurativa PR
UCB : Phase 3 Data Analysis Presented at EADV 2023 Showed Bimekizumab Achieved High Thresholds of Clinical Response in Hidradenitis Suppurativa PU
MoonLake Immunotherapeutics presents positive 12-week data from the Phase 2 MIRA trial with Nanobody® Sonelokimab for Hidradenitis Suppurativa at the European Academy of Dermatology and Venereology Congress GL
MoonLake Immunotherapeutics presents positive 12-week data from the Phase 2 MIRA trial with Nanobody® Sonelokimab for Hidradenitis Suppurativa at the European Academy of Dermatology and Venereology Congress AQ
Severance Denied: Diag Human v Volterra Fietta [2023] EWCA Civ 1107; A Potential Public Policy Warning For Litigation Funders AQ
The Legal Landscape Following The Supreme Court's Decision In PACCAR AQ
UCB : to Present New Bimekizumab Data in Hidradenitis Suppurativa, Psoriasis and Psoriatic Arthritis at EADV 2023 PU
1234NextSee all

Companies (115)

ARTHUR J. GALLAGHER & CO. 54 786 M $
Logo Arthur J. Gallagher & Co.

Arthur J. Gallagher & Co. specializes in insurance brokerage services. The group also develops risk management activity. Revenues break down by activity as follows: - insurance and reinsurance brokerage services (85.7%); - risk management and assessment ...

J&T GLOBAL EXPRESS LIMITED 9 565 M $
Logo J&T Global Express Limited

J&T Global Express Ltd is a China-based company principally engaged in global logistics services. The Company's businesses include express delivery services, cross-border logistics services, sales accessories and other services. The express delivery servi ...

KIRBY CORPORATION 6 671 M $
Logo Kirby Corporation

Kirby Corporation is a domestic tank barge operator. The Company transports bulk liquid products throughout the Mississippi River System, on the Gulf Intracoastal Waterway, and coastwise along all three United States coasts. The Company, through its marin ...

SEKTKELLEREI J.OPPMANN AG 6 M $
Logo Sektkellerei J.Oppmann AG

Sektkellerei J Oppmann AG is a Germany-based company, which is engaged in the production and distribution of sparkling wine. The Company offers sparking wine from six categories: Distinctively Unique - Traditional Fermentation in the Bottle, which compris ...

JUPITER ENERGY LIMITED 20 M $
Logo Jupiter Energy Limited

Jupiter Energy Limited is an oil exploration and production company. The Company is focused on developing its onshore assets in Western Kazakhstan. The Company holds 100% of the Block 31 permit, located in the oil rich Mangistau Basin, close to the port c ...

J SAINSBURY PLC 8 235 M $
Logo J Sainsbury plc

J Sainsbury plc is one of the British leaders of food distribution. Net sales break down by activity as follows: - food distribution (98.3%): as of 04/03/2023, owned 814 convenience stores and 595 supermarkets (Sainsbury's brand) located in the United Ki ...

J SAINSBURY PLC 8 235 M $
Logo J Sainsbury plc

J Sainsbury plc is one of the British leaders of food distribution. Net sales break down by activity as follows: - food distribution (98.3%): as of 04/03/2023, owned 814 convenience stores and 595 supermarkets (Sainsbury's brand) located in the United Ki ...

FULL MOTION BEVERAGE, INC. 755 232 $
Logo Full Motion Beverage, Inc.

Full Motion Beverage, Inc. is engaged in the business of developing, marketing, and distributing non-alcoholic beverage brands. The Company has three subsidiaries, Performaxx Brands, Inc., Mojito Brands, Inc. and J&B Beverage Distributors of NY, LLC. Perf ...

BYGGMÄSTARE ANDERS J AHLSTRÖM HOLDING AB 178 M $
Logo Byggmästare Anders J Ahlström Holding AB

Byggmastare Anders J Ahlstrom Holding publ AB is a real estate holding company engaged in the residential real estate development industry. Through its subsidiaries, the Company is engaged in renting and acquiring residential rental properties built withi ...

SIDERURGICA JL ALIPERTI SA 12 M $
Logo Siderurgica JL Aliperti SA

Siderurgica J L Aliperti SA, formerly J L Aliperti Irmaos & Companhia Ltda, is a Brazil-based company principally engaged in the steel industry. The Company is involved in the manufacture of steel products, such as springs for the automotive industry, as ...


1234Next

Insiders

Picture J. Stephen Kirby
J. Stephen Kirby

J.
Stephen Kirby
has worked as a Director at The Greater Phoenix Chamber of Commerce since 2010.


Picture J. Thornton Kirby
J. Thornton Kirby

J.
Thornton Kirby
is currently the President & Chief Executive Officer at South Carolina Hospital Association.
Prior to this, he served as Vice Chairman at Joint Commission Resources, Inc.


J. Kirby
J. Kirby

J. Scott Kirby is a businessperson who has been at the head of 8 different companies and presently holds the position of Chairman of Star Alliance Services GmbH and Chief Executive Officer at United Airlines Holdings, Inc., Chief Executive Officer at United Airlines, Inc. (a subsidiary of United Airlines Holdings, Inc.). J. Scott Kirby previously occupied the position of President for American Airlines Group, Inc. President of US Airways, Inc. President of America West Holdings Corp. President of America West Airlines, Inc. and President & Director at American Airlines, Inc. (which are all subsidiaries of American Airlines Group, Inc.) and Budget Analyst at Pentagon Corp. Mr. Kirby received a graduate degree from George Washington University and an undergraduate degree from United States Air Force Academy.


Picture Kenneth E. Kirby
Kenneth E. Kirby

Kenneth E.
Kirby
is currently working as Senior Vice President-Development at Main Line Health, Inc. since 2004.
He is also a Member at National Adoption Center.
Previously, he worked as Executive Vice President at The Franklin Institute.


Picture Kirby Ikin
Kirby Ikin

Kirby Ikin is currently the Managing Director at Asia Pacific Aerospace Consultants.
Previously, he was the Co-Chairman at National Space Society from 1999 to 2013 and the President at Deep Space Industries, Inc. Mr. Ikin completed his undergraduate degree at The University of Sydney.






Picture Peter Maxwell Kirby
Peter Maxwell Kirby

Peter Maxwell Kirby served as Chief Executive Officer & Managing Director at CSR Ltd.
from 1998 to 2003.
He was also Chairman & Chief Executive Officer at ICI Paints.
Kirby served as Chairman at Medibank Private Ltd.
from 2004 to 2007 and at DuluxGroup Ltd.
from 2010 to 2018.
He was a Director at Macquarie Bank Ltd.
(Private Banking) from 2003 to 2014 and a Non-Executive Director at Orica Ltd.
from 2003 to 2010.
Kirby also served as an Independent Non-Executive Director at Macquarie Group Ltd.
from 2007 to 2014.
He was a Member-Executive Board at Imperial Chemical Industries Ltd.
Kirby was a Member of the Business Council of Australia from 2001 to 2003.
Kirby's education includes a graduate degree from The University of Manchester, an undergraduate degree from University of Natal, an MBA from the University of the Witwatersrand, and an undergraduate degree from Rhodes University.

No results for this search